Articles related to Pediatric Allergy & Immunology

FDA Expands Pediatric Allergy Nasal Spray Use

The FDA expanded the indication for olopatadine hydrochloride and mometasone furoate nasal spray to include children aged 6 to younger than 12 years with seasonal allergic rhinitis. Approval was supported by a phase 3 trial demonstrating improved nasal symptoms versus placebo.

Adolescent Medicine August 13th 2026

Tags: ANAPHYLAXIS/ALLERGIC REACTIONS CORTICOSTEROIDS DEVICE/DRUG APPROVALS FDA PEDIATRIC ALLERGIES PHARMACOTHERAPY PRODUCT LABELING

Annals of Otology, Rhinology & Laryngology

Pediatric Allergy Testing: At What Age Is It Worth It?

A retrospective study of 606 pediatric patients found serum specific IgE testing for allergic rhinitis was frequently negative in children younger than 3 years and became more informative with age. Findings may aid diagnostic decision-making, though prospective validation is needed.

Adolescent Medicine August 13th 2026

Tags: ANAPHYLAXIS/ALLERGIC REACTIONS CLINICAL ASSESSMENT DIAGNOSTIC STEWARDSHIP PEDIATRIC ALLERGIES RISK STRATIFICATION TESTING/LABS

Trending Topics:

Articles related to Pediatric Allergy & Immunology

View More Articles On:

FDA Expands Pediatric Allergy Nasal Spray Use

Pediatric Allergy Testing: At What Age Is It Worth It?

Topics

Sources

The Healthcare Communications Network is owned and operated by IQVIA Inc. Click below to leave this site and continue to IQVIA’s Privacy Choices form

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form